IP Library Assignment 068551/0204
Patent Assignment
Reel/Frame 068551/0204

Change of Name

Recorded: 2024-08-12 Pages: 18
Assignor
ARROWHEAD RESEARCH CORPORATION
Executed: 2016-04-05
Assignee
ARROWHEAD PHARMACEUTICALS, INC.
225 SOUTH LAKE AVENUE, SUITE 1050, PASADENA, CALIFORNIA, 91101
Covered Properties (3)
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Patent: 7,947,660 →
Application: 11/373,376 →
Publication: US 2006/0223773
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Patent: 8,173,617 →
Application: 13/084,944 →
Publication: US 2011/0190381
Rnai-Mediated Inhibition of Frizzled Related Protein-1 for Treatment of Glaucoma
Patent: 9,040,494 →
Application: 13/429,913 →
Publication: US 2012/0178795
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest May 11, 2015
From: NOVARTIS AG
To: ARROWHEAD RESEARCH CORPORATION
Reel/Frame 035604/0484 →
Security Interest Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →